Research news
Novel interaction of the co-chaperone DNAJC12 with phenylalanine hydroxylase variants
Researchers from the lab of Aurora Martinez describe a novel mechanism for the degradation of enzymes involved in phenylketonuria and other neurometabolic disorders.
Hovedinnhold
Oppdatert: 05.03.2020 (Først publisert: 08.04.2019)
We showed that mutant phenylalanine hydroxylase (PAH) exhibits increased ubiquitination compared with normal PAH. We also showed that the co-chaperone DNAJC12 interacts with monoubiquitin-tagged PAH. The results indicate a role of DNAJC12 in the processing of misfolded ubiquitinated PAH.
Our image was featured on the cover of the April 2019 issue of Human Mutation.
Related content